Morten Peter Meldal

Morten Peter Meldal is a distinguished Professor of Chemistry at the University of Copenhagen's Department of Chemistry, where he has been a faculty member since 2011. He also serves as the head of the Center of Evolutionary Chemical Biology and was previously the Vice-Institute Director of Teaching (2019-2020). His academic career includes leadership roles at the Carlsberg Laboratory as Professor & Director of the SPOCC Centre (1988-2011).

Dr. Meldal's educational background features a PhD in Organic Chemistry from the Technical University of Denmark (1983), an M.Sc. in Chemical Engineering from DTU (1981), and postdoctoral training at Cambridge University and the H. C. Ørsted Institute at the University of Copenhagen.

Meldal's research spans multiple cutting-edge fields at the intersection of chemistry and biology. His pioneering work in combinatorial chemistry and click chemistry has revolutionized chemical biology approaches. He has made seminal contributions to peptide synthesis, polymer chemistry, organic synthesis automation, and the development of artificial receptors and enzymes. His expertise extends to nano-scale analytical techniques including MS and NMR, biomolecular recognition, enzyme activity studies, cellular assays, and molecular immunology. The breadth of his research portfolio demonstrates his ability to bridge fundamental chemical principles with biological applications, particularly in developing novel tools for biomedical research. His specialties include computational chemistry, chemical biology, organic chemistry, polymer science, combinatorial chemistry, enzymology, protein chemistry, GPCRs, structural chemistry, immunology, molecular recognition, catalysis, and nanomaterials.

His recent publications reveal a strong focus on Alzheimer's disease research, particularly on $$\text{A}\beta$$ peptide behavior and potential therapeutic interventions. There's also significant work on proteinase activity monitoring, peptide synthesis methodologies, and sustainable chemistry approaches. These publications demonstrate continued innovation in applying chemical principles to address challenging biological questions, particularly in neurodegenerative diseases and protease-related pathologies.

Dr. Meldal's scientific excellence has been recognized with numerous prestigious awards:

• Nobel Prize in Chemistry (2022)
• Vincent du Vigneaud Award, American Peptide Society (2011)
• Ralph F. Hirschmann Award, American Chemical Society (2009)
• Niels Bjerrum Gold Medal in Chemistry, Denmark (1996)
• The Leonidas Zervas Award, European Peptide Society (1996)

Throughout his career, Meldal has secured substantial research funding from major organizations including the Lundbeck Foundation, Novo Nordisk Foundation, Danish National Research Foundation, Danish Cancer Society, and various EU research programs. He has founded multiple companies including Combio A/S (2000), Versamatrix A/S (2002), and Betamab APS (2019), where he serves as CSO. His leadership extends to founding the Society of Combinatorial Sciences and organizing major international symposia in peptide research, including the 31st European Peptide Symposium (2010).

Meldal leads a dynamic research group focused on evolutionary chemical biology, with particular emphasis on developing novel chemical tools and methodologies. His Center of Evolutionary Chemical Biology serves as a hub for interdisciplinary research bridging chemistry, biology, and medicine. He has published more than 300 publications, holds 21 patents, and has mentored numerous students and researchers throughout his career. His work on click chemistry has had profound implications across multiple scientific disciplines, earning him the highest recognition in science with the 2022 Nobel Prize in Chemistry.